Keterangan
Weight gain is a common concern for individuals with diabetes who require insulin therapy to manage their blood sugar levels. Insulin is a hormone that regulates glucose uptake by cells, and when used to treat diabetes, it can lead to an increase in body weight for some individuals.
This weight gain is primarily due to insulin's role in promoting the storage of glucose as fat in adipose tissue and reducing the breakdown of stored fat. Insulin-induced weight gain tends to affect some people more than others, and genetic factors may play a role in determining susceptibility. Healthcare providers often emphasize the importance of monitoring caloric intake, portion sizes, and carbohydrate consumption when using insulin.Insulin therapy may lead to an increased appetite, making it important for individuals to be mindful of their eating habits.
The prognosis for diastolic dysfunction varies but is generally better than systolic heart failure, especially with early diagnosis and appropriate treatment. Patients with diastolic dysfunction require regular follow-up and monitoring to assess changes in cardiac function and adjust treatment as needed.
Ringkasan
- **Insulin Types and Weight Gain Concerns:**
- Diabetes is increasing rapidly, with a large percentage of type 2 patients eventually requiring insulin. While insulin is crucial for glycemic control, it is associated with weight gain. This weight gain can offset the benefits of glycemic control, potentially increasing A1c levels.
- **Insulin's Journey:**
- The journey of insulin has progressed from animal sources to recombinant human insulin and finally to insulin analogs with modified structures. These analogs aim to mimic physiological insulin profiles and reduce side effects.
- **Physiology and Insulin Availability:**
- In a normal day, insulin is secreted even in the basal state, not just after meals. Different types of insulin are available to mimic the body's natural insulin profile. Second-generation insulin analogs are designed to provide a flat basal insulin coverage.
- **Weight Gain in Type 1 and Type 2:**
- Weight gain is observed in both type 1 and type 2 diabetes patients on insulin. Intensive glycemic control is associated with greater weight gain.
- **Factors Leading to Weight Gain:**
- Higher insulin doses, lower baseline weight, use of short-acting insulin, and higher A1c at baseline are associated with weight gain in insulin-treated patients. The concept of "catch-up weight gain" suggests that weight is regained as glycemic control improves.
- **Reduced Glycosuria:**
- Improved glycemic control reduces glucose loss in urine (glycosuria). Conserving these calories contributes to weight gain.
- **Insulin as an Anabolic Hormone:**
- Insulin promotes fat and muscle synthesis, contributing to weight gain by shifting the body from a catabolic to an anabolic state.
- **Perceived Hypoglycemia:**
- Some patients believe they need to eat regularly when on insulin, leading to defensive snacking and excess calorie intake.
- **Relative Hypoglycemia:**
- Even if blood glucose levels are still elevated, a sudden drop from a high baseline can trigger the brain to perceive hypoglycemia, leading to increased food consumption.
- **CNS-Mediated Effects:**
- Improved brain insulin resistance can increase appetite and reduce dietary restrictions, contributing to weight gain.
- **Portal vs. Peripheral Insulin:**
- Exogenous insulin is injected subcutaneously, leading to a different distribution of insulin compared to naturally secreted insulin. This altered portal-peripheral gradient may contribute to differences in fat and muscle function, affecting weight.
- **Natural History of Weight Gain:**
- Regardless of diabetes or insulin use, weight gain tends to increase with age.
- **Mechanisms of Weight Gain:**
- Multiple factors contribute to weight gain on insulin, including central actions, catch-up weight gain, anabolic effects, reduced glycosuria, fear of hypoglycemia, and altered insulin distribution.
- **Prevention and Management:**
- Lifestyle modifications, including diet and exercise, are key. Metformin and newer drugs like SGLT2 inhibitors and GLP1 receptor agonists can help offset weight gain. Longer-acting insulin analogs may also be beneficial.
- **Comparison of Insulin Types:**
- Analog insulins are preferable as they have a reduced 'shoulder effect' associated with regular insulin which can result in defensive snacking due to the perception of hypoglycemia.
- **Detemir's Unique Properties:**
- Detemir shows less weight gain when compared to other insulins due to predictable responses, reduces snacking, effects on central appetite, and more selective delivery to the liver.
- **GLP1 RAs and Insulin:**
- Using GLP1 RAs along with insulin has demonstrated a reduction in weight gain and improved glycemic control. Co-formulations of insulin and GLP1 RAs are also available.
- **Weight Loss Strategies:**
- Weight loss strategies include intensive lifestyle interventions, drugs like orlistat, GLP1 RAs, SGLT2 inhibitors, low-carbohydrate diets, very low-energy diets, and bariatric surgery.
- **Conclusion:**
- Insulin is essential for managing diabetes. Addressing weight gain is crucial, requiring a judicious approach to insulin therapy, lifestyle modifications, and the consideration of adjunctive medications like GLP1 RAs or SGLT2 inhibitors.
Contoh Sertifikat
Tentang Pembicara
Dr. KVS Hari Kumar
Konsultan Endokrinologi, Magna Clinics, Hyderabad
Komentar
Komentar
Anda harus login untuk meninggalkan komentar.